Search results
Ionis, Astrazeneca win FDA approval of competitor to Alnylam drug
BioPharma Dive via Yahoo Finance· 5 months agoDive Brief: The Food and Drug Administration on Thursday approved a new medicine for a form of the...
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Q4 2023 Earnings Call Transcript February 21, 2024 Ionis...
Ionis Sacrifices A Breakout; Quarterly Miss Outweighs Intact Guide
Investor's Business Daily· 2 years agoIonis Pharmaceuticals kept its 2022 outlook intact Tuesday despite a broad second-quarter miss, and...
US FDA approves Ionis-AstraZeneca's nerve disease drug
Reuters via Yahoo News· 5 months agoThe U.S. Food and Drug Administration (FDA) on Thursday approved Ionis Pharmaceuticals and partner...
Ionis says rare disease drug succeeds in late-stage HAE study
BioPharma Dive via Yahoo Finance· 4 months agoThe medicine, called donidalorsen, reduced hereditary angioedema-related attacks in the Phase 3...
UPDATE 2-Ionis' metabolic disorder drug lowers high levels of a type of fat in study
Reuters via Yahoo Finance· 8 months agoIonis Pharmaceuticals said on Tuesday its experimental drug met the main goal of reducing abnormally high levels of the most common type of body fat in a late-stage trial in patients with a ...
Q2 2023 Ionis Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 10 months agoParticipants Brett P. Monia; Founder, CEO & Director; Ionis Pharmaceuticals, Inc. D. Wade Walke; SVP of IR; Ionis Pharmaceuticals, Inc. Elizabeth L. Hougen; Executive VP of Finance & CFO; Ionis ...